Propofol Is Mitochondrion-Toxic and May Unmask a Mitochondrial Disorder

Journal of Child Neurology

Volumn 31, Issue 13, 2016, Pages 1489-1494

  Finsterer, Josef ^a   Frank, Marlies ^a  

^a KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

Author keywords

electron transport; mitochondrial disorder; mitochondrion; myopathy; propofol; respiratory chain; rhabdomyolysis; side effects; toxicity

Indexed keywords

MITOCHONDRIAL PERMEABILITY TRANSITION PORE; PROPOFOL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE;

BRADYCARDIA; CLINICAL TRIAL (TOPIC); COMPLEX II DEFICIENCY; CYTOCHROME C OXIDASE DEFICIENCY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EPIDURAL HEMATOMA; HEART ARREST; HUMAN; HYPERTHERMIA; INTENSIVE CARE UNIT; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL MYOPATHY; MUSCLE BIOPSY; MUTATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROPOFOL INFUSION SYNDROME; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY CHAIN; REVIEW; ANIMAL; DRUG EFFECTS; METABOLISM; MITOCHONDRION; RISK;

ANIMALS; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; PROPOFOL; RISK;

EID: 84991206325     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073816661458     Document Type: Review

References (50)

1. Francis L, Bonilla E, Soforo E, et al. Fatal toxic myopathy attributed to propofol, methylprednisolone, and cyclosporine after prior exposure to colchicine and simvastatin. Clin Rheumatol. 2008; 27: 129-131.
2. Savard M, Dupré N, Turgeon AF, Desbiens R, Langevin S, Brunet D,. Propofol-related infusion syndrome heralding a mitochondrial disease: case report. Neurology. 2013; 81: 770-771.
3. Stelow EB, Johari VP, Smith SA, Crosson JT, Apple FS,. Propofol-associated rhabdomyolysis with cardiac involvement in adults: chemical and anatomic findings. Clin Chem. 2000; 46: 577-581.
4. Schroeppel TJ, Fabian TC, Clement LP, et al. Propofol infusion syndrome: a lethal condition in critically injured patients eliminated by a simple screening protocol. Injury. 2014; 45: 245-249.
5. Ramaiah R, Lollo L, Brannan D, Bhananker SM,. Propofol infusion syndrome in a super morbidly obese patient (BMI = 75). Int J Crit Illn Inj Sci. 2011; 1: 84-86.
6. Niezgoda J, Morgan PG,. Anesthetic considerations in patients with mitochondrial defects. Paediatr Anaesth. 2013; 23: 785-793.
7. Vanlander AV, Jorens PG, Smet J, et al. Inborn oxidative phosphorylation defect as risk factor for propofol infusion syndrome. Acta Anaesthesiol Scand. 2012; 56: 520-525.
8. Cray SH, Robinson BH, Cox PN,. Lactic acidemia and bradyarrhythmia in a child sedated with propofol. Crit Care Med. 1998; 26: 2087-2092.
9. Wolf A, Weir P, Segar P, Stone J, Shield J,. Impaired fatty acid oxidation in propofol infusion syndrome. Lancet. 2001; 357 (9256): 606-607.
10. Mehta N, DeMunter C, Habibi P, Nadel S, Britto J,. Short-term propofol infusions in children. Lancet. 1999; 354: 866-867.
11. Sharma AD, Erb T, Schulman SR, Sreeram G, Slaughter TF,. Anaesthetic considerations for a child with combined Prader-Willi syndrome and mitochondrial myopathy. Paediatr Anaesth. 2001; 11: 488-490.
12. Shibukawa K, Kawamata M, Seki S, Narimatsu E, Namiki A,. The use of propofol combined with nitrous oxide and fentanyl in anesthetic management of a patient with mitochondrial encephalomyopathy. Masui. 2002; 51: 888-891.
13. Cheam EW, Critchley LA,. Anesthesia for a child with complex I respiratory chain enzyme deficiency. J Clin Anesth. 1998; 10: 524-527.
14. Kocamanoglu IS, Sarihasan E,. Anesthetic management of a pediatric patient with leigh syndrome. Braz J Anesthesiol. 2013; 63: 220-222.
15. Saito J, Noguchi S, Matsumoto A, et al. Anesthetic management of laparoscopic nephrectomy for a renal cancer patient with distal myopathy of rimmed vacuole. Masui. 2015; 64: 164-167.
16. Redshaw C, Stewart C,. Anesthetic agents in patients with very long-chain acyl-coenzyme A dehydrogenase deficiency: a literature review. Paediatr Anaesth. 2014; 24: 1115-1119.
17. Uno A, Niiyama Y, Tachibana N, Yamauchi M, Watanabe A, Yamakage M,. Anesthetic management in a patient with spinal progressive muscle atrophy and compromised severe restrictive respiratory dysfunction. Masui. 2012; 61: 830-833.
18. Matsuda H, Arai M, Okamoto H,. Total intravenous anesthesia for a patient with Fukuyama congenital muscular dystrophy undergoing scoliosis surgery. Masui. 2014; 63: 650-653.
19. Tokarz A, Gaszyński T, Gaszyński W, Arkuszewski P,. General anaesthesia with remifentanil and propofol for a patient with centronuclear (myotubular) myopathy. Eur J Anaesthesiol. 2002; 19: 842-844.
20. Etoh T,. Anesthetic management of a child with myotubular myopathy who underwent two operations using only total intravenous anesthesia (TIVA). Masui. 2012; 61: 742-745.
21. Abe M, Hayashi H, Hayashi Y, Mashimo T,. Application of bispectral index (BIS) monitoring to anesthetic management of posterior spinal fusion in a patient with Duchenne muscular dystrophy. Masui. 2002; 51: 765-768.
22. Egi M, Tokioka H, Chikai T, et al. Propofol anesthesia for a patient with progressive muscular dystrophy. Masui. 2002; 51: 196-198.
23. de Resende MA, da Silva EV, Nascimento OJ, Gemal AE, Quintanilha G, Vasconcelos EM,. Total intravenous anesthesia (TIVA) in an infant with Werdnig-Hoffmann disease. Case report. Rev Bras Anestesiol. 2010; 60: 170-175.
24. Hansen TG,. Propofol infusion syndrome in children. Ugeskr Laeger. 2005; 167: 3672-3675.
25. Halestrap AP, Clarke SJ, Javadov SA,. Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection. Cardiovasc Res. 2004; 61: 372-385.
26. Mtaweh H, Baylr H, Kochanek PM, Bell MJ,. Effect of a single dose of propofol and lack of dextrose administration in a child with mitochondrial disease: a case report. J Child Neurol. 2014; 29: NP40-46.
27. Klockgether-Radke A, Henze T, Braun U, Kettler D,. General anesthesia in two patients with mitochondrial myopathy. Anaesthesist. 1993; 42: 111-114.
28. Kawagoe I, Odoh M, Koh K, Takada T, Inada E,. A case of intraoperative cardiac arrest in a patient with mitochondrial encephalomyopathy undergoing lung resection. Masui. 2013; 62: 431-434.
29. Branca D, Roberti MS, Lorenzin P, Vincenti E, Scutari G,. Influence of the anesthetic 2,6-diisopropylphenol on the oxidative phosphorylation of isolated rat liver mitochondria. Biochem Pharmacol. 1991; 42: 87-90.
30. Schenkman KA, Yan S,. Propofol impairment of mitochondrial respiration in isolated perfused guinea pig hearts determined by reflectance spectroscopy. Crit Care Med. 2000; 28: 172-177.
31. Vanlander AV, Okun JG, de Jaeger A, et al. Possible pathogenic mechanism of propofol infusion syndrome involves coenzyme q. Anesthesiology. 2015; 122: 343-352.
32. Rigoulet M, Devin A, Avéret N, Vandais B, Guérin B,. Mechanisms of inhibition and uncoupling of respiration in isolated rat liver mitochondria by the general anesthetic 2,6-diisopropylphenol. Eur J Biochem. 1996; 241: 280-285.
33. Branca D, Vincenti E, Scutari G,. Influence of the anesthetic 2,6-diisopropylphenol (propofol) on isolated rat heart mitochondria. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1995; 110: 41-45.
34. Miyamoto Y, Miyashita T, Takaki S, Goto T,. Perioperative considerations in adult mitochondrial disease: a case series and a review of 111 cases. Mitochondrion. 2015; 26: 26-32.
35. Gozal D, Goldin E, Shafran-Tikva S, Tal D, Wengrower D,. Leigh syndrome: anesthetic management in complicated endoscopic procedures. Paediatr Anaesth. 2006; 16: 38-42.
36. Ibáñez C, Fernández-González I,. Emergency anesthesia in a woman with mitochondrial neurogastrointestinal encephalopathy. Rev Esp Anestesiol Reanim. 2011; 58: 585-587.
37. Farag E, Deboer G, Cohen BH, Niezgoda J,. Metabolic acidosis due to propofol infusion. Anesthesiology. 2005; 102: 697-698.
38. Yamashita A, Iimori T,. Total intravenous anesthesia for a patient with mitochondrial encephalomyopathy who underwent laparoscopic cholecystotomy. Masui. 2011; 60: 961-963.
39. Calzavacca P, Schmidt W, Guzzi M,. General anaesthesia for laparoscopic cholecystectomy in a patient with the Kearns-Sayre syndrome. Case Rep Anesthesiol. 2011; 2011: 806086.
40. Imai Y, Kitamura T, Kawamura G, Nakamura M, Yamada Y,. Anesthetic management of emergency total gastrectomy in a patient with mitochondrial encephalomyopathy: a case of gastric perforation accompanied by systemic inflammatory response syndrome. Masui. 2010; 59: 765-769.
41. Park JS, Baek CW, Kang H, et al. Total intravenous anesthesia with propofol and remifentanil in a patient with MELAS syndrome-a case report. Korean J Anesthesiol. 2010; 58: 409-412.
42. Ortiz-Gómez JR, Souto-Ferro JM,. Anesthesia for a patient with mitochondrial respiratory chain complex III deficiency. Rev Esp Anestesiol Reanim. 2006; 53: 575-579.
43. Tatsumi Y, Nakashima M, Kitao T, et al. Anesthetic management of a patient with mitochondrial encephalomyopathy under total intravenous anesthesia. Masui. 2006; 55: 1228-1230.
44. Hara K, Sata T, Shigematsu A,. Anesthetic management for cardioverter-defibrillator implantation in a patient with Kearns-Sayre syndrome. J Clin Anesth. 2004; 16: 539-541.
45. Heinke W, Schaffranietz L,. Anaesthesia for combined pancreatic and renal transplantation in a patient with mitochondrial encepahalomyopathy-a case report. Anaesthesiol Reanim. 2004; 29: 87-90.
46. Kushikata T, Yatsu Y, Kubota T, Matsuki A,. Total intravenous anesthesia with propofol, ketamine, and fentanyl (PFK) for a patient with mitochondrial myopathy. Masui. 2004; 53: 178-180.
47. Thiel A, Ritzka M, Saur G,. Anesthesia in mitochondrial encephalomyopathies. Anasthesiol Intensivmed Notfallmed Schmerzther. 2001; 36: 437-439.
48. Sabaté S, Ferrándiz M, Paniagua P, Villamor JM, Vilanova F, Villar-Landeira JM,. Anesthesia in Kearns-Sayre syndrome (mitochondrial myopathy). Rev Esp Anestesiol Reanim. 1996; 43: 255-257.
49. Breucking E, Mortier W, Lampert R, Brandt L,. Anesthesia and intensive therapy for a patient with mitochondrial myopathy. Anaesthesist. 1993; 42: 719-723.
50. Krajcová A, Waldauf P, Andel M, Duška F,. Propofol infusion syndrome: a structured review of experimental studies and 153 published case reports. Crit Care. 2015; 19: 398.